Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Capital Expenditures of $713000.0 for Q1 2026, up 18.05% on a YoY basis from $604000.0 in Q1 2025, and up 24.22% quarter-over-quarter from $574000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) Capital Expenditures (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Capital Expenditures for 9 years, with the latest figure at $713000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 18.05% year-over-year to $713000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 34.59% YoY), and the FY2025 full-year result was $2.4 million, up 90.28% from the prior year.
- Capital Expenditures for Q1 2026 stood at $713000.0, up from $574000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $9.8 million in Q2 2022, with the low at $12000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $1.5 million across 5 years, with a median of $574000.0 in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 5630.41% — and 2024, when it tumbled 99.43%.
- Bicycle Therapeutics' Capital Expenditures stood at $1.4 million in 2022, then slumped by 96.48% to $51000.0 in 2023, then surged by 621.57% to $368000.0 in 2024, then jumped by 55.98% to $574000.0 in 2025, then rose by 24.22% to $713000.0 in 2026.
- The last three Capital Expenditures figures came in at $713000.0 (Q1 2026), $574000.0 (Q4 2025), and $674000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | 713,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 713,000.00 |
| Mar 31, 2026 | 713,000.00 |
| Dec 31, 2025 | 574,000.00 |
| Dec 31, 2025 | 574,000.00 |
| Sep 30, 2025 | 674,000.00 |
| Sep 30, 2025 | 674,000.00 |
| Jun 30, 2025 | 498,000.00 |
| Jun 30, 2025 | 498,000.00 |
| Mar 31, 2025 | 604,000.00 |
| Mar 31, 2025 | 604,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Dec 31, 2023 | 51,000.00 |